Table 1:
Genotype | Patients (%) N=108 |
Admissions (%) N=236 |
---|---|---|
Hb SS/Sβ0 thalassemia | 80 (74) | 182 (77) |
Hb SC | 24 (22) | 45 (19) |
HbSβ+ thalassemia | 4 (4) | 9 (4) |
SCD Modifying Therapy | ||
Hydroxyurea | 53 (49) | 122 (52) |
HU/Transfusion | 10 (9) | 50 (21) |
No therapy | 45 (42) | 64 (27) |
VOC Frequency | ||
< 3 admissions | 87 (81) | 109 (46) |
≥ 3 admissions | 21 (19) | 127 (54) |